Alioth Finance: Inflation Calculator. U.S. Official Inflation Data. Retrieved 18 February, 2022, from (2022). https://www.officialdata.org/

Barbosa, C., Dowd, W.N., Zarkin, G.: Economic evaluation of interventions to address opioid misuse: A systematic review of methods used in simulation modeling studies. Value Health. 23(8), 1096–1108 (2020)

Article  PubMed  Google Scholar 

Baser, O., Chalk, M., Fiellin, D.A., Gastfriend, D.R.: Cost and utilization outcomes of opioid-dependence treatments. Am. J. Manag Care. 17(Suppl8:S235-48) (2011)

Beaulieu, E., DiGennaro, C., Stringfellow, E., Connolly, A., Hamilton, A., Hyder, A., Cerda, M., Keyes, K.M., Jalali, M.: Economic evaluation in opioid modeling: systematic review. Value Health. 24(2), 158–173 (2020)

Besson, J., Beck, T., Wiesbeck, G., Hämmig, R., Kuntz, A., Abid, S., Stohler, R.: Opioid maintenance therapy in Switzerland: An overview of the Swiss IMPROVE study. Swiss Med. Wkly. 144, w13933 (2014)

CAS  PubMed  Google Scholar 

Briggs, A.H.: Decision modelling for health economic evaluation. Oxford University Press (2006)

Briggs, A.H., O’Brien, B.J.: The death of cost-minimization analysis? Health Econ. 10(2), 179–184 (2001)

Article  CAS  PubMed  Google Scholar 

Caplehorn, J.R.M., Batey, R.G.: Methadone maintenance in Australia. J. Drug Issues. 22(3), 661–678 (1992)

Article  Google Scholar 

Centers for Disease Control and Prevention: Understanding the opioid overdose epidemic. Opioids. Retrieved 1 February, 2023, from (2022). http://cdc.gov/opioids/basics/epidemic.html

Choi, S.A., Yan, C.H., Gastala, N.M., Touchette, D.R., Stranges, P.M.: Cost-effectiveness of full and partial opioid agonists for opioid use disorder in outpatient settings: United States healthcare sector perspective. J. Subst. Use Addict. Treat. 160, 209237 (2024)

Article  CAS  PubMed  Google Scholar 

Claxton, K.: The irrelevance of inference: A decision-making approach to the stochastic evaluation of health care technologies. J. Health Econ. 18(3), 341–364 (1999)

Article  CAS  PubMed  Google Scholar 

Claxton, K., Sculpher, M., McCabe, C., Briggs, A., Akehurst, R., Buxton, M., Brazier, J., O’Hagan, T.: Probabilistic sensitivity analysis for NICE technology assessment: Not an optional extra. Health Econ. 14(4), 339–347 (2005)

Article  PubMed  Google Scholar 

Dakin, H., Wordsworth, S.: Cost-minimisation analysis versus cost-effectiveness analysis, revisited. Health Econ. 22(1), 22–34 (2013)

Article  PubMed  Google Scholar 

Delargy, I., Crowley, D., Van Hout, M.C.: Twenty years of the methadone treatment protocol in Ireland: Reflections on the role of general practice. Harm Reduct. J. 16(1), 5–5 (2019)

Article  PubMed  PubMed Central  Google Scholar 

Drummond, M., Stoddart, G., Torrance, G.: Methods for the economic evaluation of health care programmes. Oxford University Press, New York (1987)

Google Scholar 

Drummond, M., O’Brien, B., Stoddart, G., Torrance, G.: Methods for theeconomic evaluation of health care programmes. Oxford University Press, New York (1997)

Google Scholar 

Drummond, M., Sculpher, M., Torrance, G., O’Brien, B., Stoddart, G.: Methods for the economic evaluation of health care programmes. Oxford University Press, New York (2005)

Book  Google Scholar 

Drummond, M., Sculpher, M., Claxton, K., Stoddart, G., Torrance, G.: Methods for the economic evaluation of health care programmes. Oxford University Press, New York (2015)

Google Scholar 

Dydyk, A., Jain, N., Gupta, M.: Opioid use disorder. StatPearls Publishing, Treasure Island, FL (2022)

Google Scholar 

Fiellin, D., O’Connor, P., Chawarski, M., Pakes, J., Pantalon, M., Schottenfeld, R.: Methadone maintenance in primary care: A randomized controlled trial. JAMA. 286, 1724–1731 (2001)

Article  CAS  PubMed  Google Scholar 

Fiellin, D., Pantalon, M., Chawarski, M., Moore, B., Sullivan, L., O’Connor, P., Schottenfeld, R.: Counseling plus buprenorphine-naloxone therapy for opioid dependence. N Engl. J. Med. 355, 365–374 (2006)

Article  CAS  PubMed  Google Scholar 

Fiellin, D.A., Moore, B.A., Sullivan, L.E., Becker, W.C., Pantalon, M.V., Chawarski, M.C., Barry, D.T., O’Connor, P.G., Schottenfeld, R.S.: Long-term treatment with buprenorphine/naloxone in primary care: Results at 2–5 years. Am. J. Addict. 17(2), 116–120 (2008)

Article  PubMed  Google Scholar 

Glick, H.A., Doshi, J.A., Sonnad, S.S., Polsky, D.: Economic evaluation in clinical trials, OUP Oxford. (2014)

Gossop, M., Stewart, D., Browne, N., Marsden, J.: Methadone treatment for opiate dependent patients in general practice and specialist clinic settings: Outcomes at 2-year follow-up. J. Subst. Abuse Treat. 24(4), 313–321 (2003)

Article  PubMed  Google Scholar 

Hser, Y.-I., Hoffman, V., Grella, C.E., Anglin, M.D.: A 33-year follow-up of narcotics addicts. Arch. Gen. Psychiatry. 58(5), 503–508 (2001

Article  CAS  PubMed  Google Scholar 

Hser, Y.-I., Evans, E., Huang, D., Weiss, R., Saxon, A., Carroll, K.M., Woody, G., Liu, D., Wakim, P., Matthews, A.G., Hatch-Maillette, M., Jelstrom, E., Wiest, K., McLaughlin, P., Ling, W.: Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial. Addict. (Abingdon England). 111(4), 695–705 (2016)

Article  Google Scholar 

Institute for Clinical and Economic Review: 2020–2023 Value assessment framework: Response to public comments. Value Health. 24(2), 244–249 (2020)

Google Scholar 

Jones, E.S., Moore, B.A., Sindelar, J.L., O’Connor, P.G., Schottenfeld, R.S., Fiellin, D.A.: Cost analysis of clinic and office-based treatment of opioid dependence: Results with methadone and buprenorphine in clinically stable patients. Drug Alcohol Depend. 99(1–3), 132–140 (2009)

Article  PubMed  Google Scholar 

Karlsson, G., Johannesson, M.: The decisionrules of cost-effectiveness analysis. Pharmacoeconomics. 9(2), 113–120 (1996)

CAS  Google Scholar 

King, J.B., Sainski-Nguyen, A.M., Bellows, B.K.: Office-based buprenorphine versus clinic-based methadone: A cost-effectiveness analysis. J. Pain Palliat. Care Pharm. 30(1), 55–65 (2016)

Google Scholar 

Klingemann, H.K.: Drug treatment in Switzerland: Harm reduction, decentralization and community response. Addiction. 91(5), 723–736 (1996)

Article  CAS  PubMed  Google Scholar 

Lobmaier, P., Kunøe, K.H., Bjørndal, N. A: Sustained-release Naltrexone for Opioid Dependence. Cochrane Database Syst Rev (2008)

Mattick, R.P., Breen, C., Kimber, J.,Davoli, M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev, Issue 2 (2014)

Mattick, R.P., Breen, C.,Kimber, J., Davoli, M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev, Issue 3 (2009)

McCarty, D., Bougatsos, C., Chan, B., Hoffman, K.A., Priest, K.C., Grusing, S., Chou, R.: Office-Based methadone treatment for opioid use disorder and pharmacy dispensing: A scoping review. Am. J. Psychiatry. 178(9), 804–817 (2021)

Article  PubMed  PubMed Central  Google Scholar 

Menzel, P.T.: How should willingness-to-pay values of quality-adjusted life-years be updated and according to whom? AMA J. Ethics. 23(8), E601–606 (2021)

Article  PubMed  Google Scholar 

Murphy, S.M.: The cost of opioid use disorder and the value of aversion. Drug Alcohol Depend. 217, 108382 (2020)

Article  PubMed  PubMed Central  Google Scholar 

National Academies of Sciences, Engineering, and Medicine; Health and, Medicine Division; Board on Health Sciences Policy; Committee on Medication-Assisted Treatment for Opioid Use Disorder; Mancher, M., Leshner, A.I., editors. Medications for opioid use disorder save lives. The effectiveness of medication-based treatment for opioid use disorder. Washington (DC), National Academies Press (US). (2019)

National Academies of Sciences, Engineering and Medicine; Action Collaborative on Countering the U.S. Opioid Epidemic; Health and Medicine Division; Board on Health Care Services; Board on Health Sciences Policy; Stroud, C., Bain, L. editors. Methadone treatment for opioid use disorder: Improving access through regulatory and legal change: Proceedings of a workshop. Washington (DC) National Academies Press (US). (2022)

Onuoha, E.N., Leff, J.A., Schackman, B.R., McCollister, K.E., Polsky, D., Murphy, S.M.: Economic evaluations of pharmacologic treatment for opioid use disorder: A systematic literature review. Value Health. 24(7), 1068–1083 (2021)

Article  PubMed  PubMed Central  Google Scholar 

Priest, K.C., Gorfinkel, L., Klimas, J., Jones, A.A., Fairbairn, N., McCarty, D.: Comparing Canadian and United States opioid agonist therapy policies. Int. J. Drug Policy. 74, 257–265 (2019)

Article  PubMed  PubMed Central  Google Scholar 

Qian, G., Humphreys, K., Goldhaber-Fiebert, J.D., Brandeau, M.L.: Estimated effectiveness and cost-effectiveness of opioid use disorder treatment under proposed U.S. regulatory relaxations: A model-based analysis. Drug Alcohol Depend. 256, 111112 (2024)

Article  CAS  PubMed  PubMed Central  Google Scholar 

Redko, C., Rapp, R.C., Carlson, R.G.: Pathways of substance users linking (or not) with treatment. J. Drug Issues. 37(3), 597–618 (2007)

Article  PubMed  PubMed Central  Google Scholar 

Sanders, G.D., Neumann, P.J., Basu, A., Brock, D.W., Feeny, D., Krahn, M., Kuntz, K.M., Meltzer, D.O., Owens, D.K., Prosser, L.A., Salomon, J.A., Sculpher, M.J., Trikalinos, T.A., Russell, L.B., Siegel, J.E., Ganiats, T.G.: Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: Second panel on cost-effectiveness. Health Med. Jama. 316(10), 1093–1103 (2016)

Google Scholar 

Senn, S.J.: Clinical trials and epidemiology. J. Clin. Epidemiol. 43(6), 628–632 (1990)

Article  CAS  PubMed  Google Scholar 

Singh, G.K., Kim, I.E., Girmay, M., Perry, C., Daus, G.P., Vedamuthu, I.P., De Los Reyes, A.A., Ramey, C.T., Martin, E.K., Allender, M.: Opioid epidemic in the United States: Empirical trends, and a literature review of social determinants and epidemiological, pain management, and treatment patterns. Int. J. MCH AIDS. 8(2), 89–100 (2019)